This article is based on a poster originally authored by Archana Bettadapur, Adam Barner, Melissa Netwal, Sanika Khare, Cam Jansen, and Dominic Skinner. Many epigenetics applications leverage the ...
The MarketWatch News Department was not involved in the creation of this content. -- Study published in 'Cell Reports Methods' demonstrates the strength of Tagomics' platform for epigenomic biomarker ...
Native Read Sequencing for Methylation Profiling in Cancer and Neurodegenerative Disease Diagnostics
Methylation analysis holds significant promise for clinical diagnostics, yet its use has been limited due to challenges posed by legacy technologies that undermine clinical applicability, such as ...
DNA methylation is a highly studied epigenetic modification that regulates genome function and plays key roles in development and disease 1. It is linked to a broad range of conditions, including ...
Genomic DNA is organized into chromatin via nucleosomes, regulating its accessibility for critical biological processes such as transcription, replication, and epigenetic modification. The dynamic ...
- TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. - Preserves DNA integrity in challenging ...
YD Bio Limited ('YD Bio” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results